Myrtle Potter to Speak at 'The Global Leaders Healthcare Forum' in San Francisco on January 10

SAN FRANCISCO, Nov. 30, 2011 – Myrtle Potter, one of America’s foremost healthcare leaders, will speak to a unique gathering of investors and CEOs in healthcare, biotech and pharma at The Global Leaders Healthcare Forum on Tuesday, Jan. 10, 2012.
By: The Global Leaders
Nov. 30, 2011 - PRLog -- Contact: William Adler, Belvedere Communications, 203 438-5085


SAN FRANCISCO, November 30, 2011 – Myrtle Potter, former President and CEO of Genentech, Inc., and one of America’s foremost healthcare leaders for three decades, will speak at The Global Leaders’ 2nd Annual Healthcare Forum, “Eliminating the Gap between Innovation and Resources,” on Tuesday, January 10, 2012, at the Marines’ Memorial Club.  The forum will bring together hundreds of CEOs in healthcare, biotech and pharmaceutical companies to meet with institutional investors to discuss new approaches to solving the global healthcare crisis.

The host organization is The Global Leaders, a digital community for CEOs and other senior-level executives in business, government, education and philanthropy.  The Global Leaders has about 2 million members who have held senior executive leadership positions in companies that drive more than 50 percent of the world’s Gross Domestic Product.

The January 10th forum will provide a dialogue among industry experts through speeches, panels, interactive table discussions and informal networking.  

“There is a gap between innovators who need funding and investors who have money but seek innovation,” said George Bickerstaff, Executive Chairman of The Global Leaders, and Partner and Managing Director of M.M. Dillon LLC.  “None of us can solve this alone.  We urgently need new leadership if we are going to provide a bright and healthy future for our children.”

A brochure with details of forum is at:  .

To register: .

Myrtle Potter has extensive experience leading large pharmaceutical manufacturers, biotechnology companies, and driving personalized medicine, healthcare reform and global health strategies for neglected diseases to better serve the needs of healthcare companies, consumers and patients worldwide. Today she is CEO of Myrtle Potter & Company, a global life sciences and healthcare consulting firm.  She also operates Myrtle Potter Media, Inc., a consumer healthcare company.  At Genentech, from 2000 to 2005, she helped to achieve record sales and earnings growth and launched several breakthrough molecules including AvastinTM, the first antiangiogenesis drug and one of the most successful products introduced for the treatment of cancer.  She also directed the launch of the drug XolairTM, the first monoclonal antibody introduced for the treatment of allergic asthma.

Previously, Potter was president of Bristol-Myers Squibb’s $4 billion U.S. Cardiovascular and Metabolics business, where she led the launch of four products including the antiplatelet drug PlavixTM, which became the fastest-growing product in the pharmaceutical industry at the time and ultimately the largest selling pharmaceutical product in the world.  Before that, she worked at Merck and Co Inc., where she established the new pharmaceutical company today known as AstraZeneca.  She directed the marketing of the antiulcer drug PrilosecTM and set it on course to become the largest-selling pharmaceutical product in the world at that time.  A sought-after speaker before business, pharmaceutical and consumer groups on healthcare and life science topics, Potter is an on-air business contributor to the NBC television network including CNBC, MSNBC and NBC, and is on the Board of Directors of Medco Health Solutions, Inc. and Everyday Health, Inc. and is a trustee of the University of Chicago.

Other distinguished speakers at the forum will include conference co-chair Dr. Margaret Liu, Vice Chairman, International Vaccine Institute, and Harry Kraemer, Executive Partner, Madison Dearborn.  Evening activities include a reception and dinner sponsored by CTPartners and featuring speakers Dr. Molly Coye, Chief Innovation Officer, UCL Health Systems; John Figueroa, CEO of Omnicare; and Mark Sirangelo, Chairman, Sierra Nevada Space Systems.  Lead sponsor for the forum is CTPartners.  Other sponsors are CorpShorts, AVG, HSM, Group50, Remerinc, M.M. Dillon & Co., Synergetics, TheConferenceForum and Latin Vision.

For more information, visit or .  

Follow The Global Leaders on Twitter at @TGLeaders and the Healthcare Forum at #TGLhealth .

# # #

The Global Leaders is the largest network of senior executives in business, government, philanthropy and education, with over 1,200 professional development courses, a bookstore and verified networking groups structured around how business is done.

Like PRLog?
Click to Share